ALK signaling and target therapy in anaplastic large cell lymphoma

被引：38

作者：

Tabbo, Fabrizio ^{[1
]}

Barreca, Antonella ^{[1
]}

Piva, Roberto ^{[1
,2
]}

Inghirami, Giorgio ^{[1
,2
]}

机构：

[1] Univ Torino, Ctr Expt Res & Med Studies, Dept Pathol, Via Santena 7, I-10126 Turin, Italy

[2] NYU, Sch Med, Dept Pathol, Canc Ctr, New York, NY USA

来源：

FRONTIERS IN ONCOLOGY | 2012年 / 2卷

关键词：

anaplastic large cell lymphoma; chimeric fusion proteins; signaling pathways; molecular targeted therapy; anaplastic lymphoma kinase;

D O I：

10.3389/fonc.2012.00041

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The discovery by Morris et al. (1994) of the genes contributing to the t(2;5)(p23;q35) translocation has laid the foundation for a molecular based recognition of anaplastic large cell lymphoma and highlighted the need fora further stratification of T-cell neoplasia. Likewise the detection of anaplastic lymphoma kinase (ALK) genetic lesions among many human cancers has defined unique subsets of cancer patients, providing new opportunities for innovative therapeutic interventions. The objective of this review is to appraise the molecular mechanisms driving ALK-mediated transformation, and to maintain the neoplastic phenotype. The understanding of these events will allow the design and implementation of novel tailored strategies for a well-defined subset of cancer patients.

引用

页数：12

共 127 条

[1] A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocation [J].

Adam, P ;

Katzenberger, T ;

Seeberger, H ;

Gattenlöhner, S ;

Wolf, J ;

Steinlein, C ;

Schmid, M ;

Müller-Hermelink, HK ;

Ott, G .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (11) :1473-1476

[2] CD4 T-helper responses to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large-cell lymphoma [J].

Ait-Tahar, Kamel ;

Barnardo, Martin C. N. ;

Pulford, Karen .

CANCER RESEARCH, 2007, 67 (05) :1898-1901

[3] B and CTL responses to the ALK protein in patients with ALK-positive ALCL [J].

Ait-Taharl, K ;

Cerundolo, V ;

Banham, AH ;

Hatton, C ;

Blanchard, T ;

Kusec, R ;

Becker, M ;

Smith, GL ;

Pulford, K .

INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (03) :688-695

[4] The Anaplastic Lymphoma Kinase Controls Cell Shape and Growth of Anaplastic Large Cell Lymphoma through Cdc42 Activation [J].

Ambrogio, Chiara ;

Voena, Claudia ;

Manazza, Andrea D. ;

Martinengo, Cinzia ;

Costa, Carlotta ;

Kirchhausen, Tomas ;

Hirsch, Emilio ;

Inghirami, Giorgio ;

Chiarle, Roberto .

CANCER RESEARCH, 2008, 68 (21) :8899-8907

[5] NPM-ALK Oncogenic Tyrosine Kinase Controls T-Cell Identity by Transcriptional Regulation and Epigenetic Silencing in Lymphoma Cells [J].

Ambrogio, Chiara ;

Martinengo, Cinzia ;

Voena, Claudia ;

Tondat, Fabrizio ;

Riera, Ludovica ;

di Celle, Paola Francia ;

Inghirami, Giorgio ;

Chiarle, Roberto .

CANCER RESEARCH, 2009, 69 (22) :8611-8619

[6] Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma [J].

Amin, HM ;

McDonnell, TJ ;

Ma, YP ;

Lin, Q ;

Fujio, Y ;

Kunisada, K ;

Leventaki, V ;

Das, P ;

Rassidakis, GZ ;

Cutler, C ;

Medeiros, LJ ;

Lai, R .

ONCOGENE, 2004, 23 (32) :5426-5434

[7] Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma [J].

Amin, HM ;

Medeiros, LJ ;

Ma, Y ;

Feretzaki, M ;

Das, P ;

Leventaki, V ;

Rassidakis, GZ ;

O'Connor, SL ;

McDonnell, TJ ;

Lai, R .

ONCOGENE, 2003, 22 (35) :5399-5407

[8] Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma [J].

Ansell, Stephen M. ;

Horwitz, Steven M. ;

Engert, Andreas ;

Khan, Khuda Dad ;

Lin, Thomas ;

Strair, Roger ;

Keler, Tibor ;

Graziano, Robert ;

Blanset, Diann ;

Yellin, Michael ;

Fischkoff, Steven ;

Assad, Albert ;

Borchmann, Peter .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) :2764-2769

[9] Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells [J].

Armstrong, F ;

Duplantier, MM ;

Trempat, P ;

Hieblot, C ;

Lamant, L ;

Espinos, E ;

Racaud-Sultan, C ;

Allouche, M ;

Campo, E ;

Delsol, G ;

Touriol, C .

ONCOGENE, 2004, 23 (36) :6071-6082

[10] Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-γ to mediate its mitogenicity [J].

Bai, RY ;

Dieter, P ;

Peschel, C ;

Morris, SW ;

Duyster, J .

MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) :6951-6961

← 1 2 3 4 5 6 7 8 9 10 →